Skip to content

Cash ratio at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.2×-0.1×
Danaher logo
DanaherDHR
0.8×+0.5×
Azenta logo
AzentaAZTA
0.5×
LeMaitre Vascular logo
LeMaitre VascularLMAT
0.8×-0.2×
TEC
Bio-TechneTECH
1.4×+0.5×
CryoPort, Inc. logo
CryoPort, Inc.CYRX
1.2×+0.7×

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on the most recent quarter.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's cash ratio?
BioLife Solutions (BLFS) reported cash ratio of 1.3× in Q1 2026.
How has BioLife Solutions's cash ratio changed year-over-year?
BioLife Solutions's cash ratio decreased by 48.2% year-over-year, from 2.4× to 1.3×.
What is the long-term trend for BioLife Solutions's cash ratio?
Over 5 years (2020 to 2025), BioLife Solutions's cash ratio has grown at a -24.4% compound annual growth rate (CAGR), from 5.8× to 1.4×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.